Corrigendum to “Endocan is useful biomarker of survival and severity in sepsis” [Microvasc. Res. 93 (2014) 92–97](S0026286214000648)(10.1016/j.mvr.2014.04.004);Endocan is useful biomarker of survival and severity in sepsis

Microvascular Research

Volumn 93, Issue , 2014, Pages 92-97

  Mihajlovic, Dunja M ^a   Lendak, Dajana F ^b   Brkic, Snezana V ^b   Draskovic, Biljana G ^b   Mitic, Gorana P ^b   Novakov Mikic, Aleksandra S ^c   Cebovic, Tatjana N ^c  

^a Emergency Centre   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

APACHE; Coagulation; Endocan; Endothelium; Hemostasis; Infection; MODS; Prognosis; Sepsis; Shock

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOCAN; PEPTIDES AND PROTEINS; PROCALCITONIN; UNCLASSIFIED DRUG; CALCITONIN; ESM1 PROTEIN, HUMAN; PROTEIN PRECURSOR; PROTEOGLYCAN; TUMOR PROTEIN;

ADULT; APACHE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATALITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL; AGED; AREA UNDER THE CURVE; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; METABOLISM; MIDDLE AGED; ORGAN DYSFUNCTION SCORE; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; UPREGULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APACHE; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASM PROTEINS; ORGAN DYSFUNCTION SCORES; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; PROTEOGLYCANS; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84901233765     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2020.103992     Document Type: Erratum

References (36)

1. Abid M.R., Yi X., Yano K., Shih S.C., Aird W.C. Vascular endocan is preferentially expressed in tumor endothelium. Microvasc. Res. 2006, 72:136-145.
2. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., et al. Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med. 2002, 28:108-121.
3. Bechard D., Meignin V., Scherpereel A., Oudin S., Kervoaze G., Bertheau P., et al. Characterization of the secreted form of endothelial cell-specific molecule 1 by specific monoclonal antibodies. J. Vasc. Res. 2000, 37:417-442.
4. Bechard D., Gentina T., Delehedde M., Scherpereel A., Lyon M., Aumercier M., et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J. Biol. Chem. 2001, 276(51):48341-48349.
5. Bone R., Balk R., Cerra F., Dellinger R., Fein A., Knaus W., et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Chest 1992, 101(6):1644-1655. American College of Chest Physicians/Society of Critical Care Medicine.
6. Brun-Buisson C., Meshaka P., Pinton P., Vallet B., EPISEPSIS Study Group EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004, 30(4):580-588.
7. Charalampos P., Vincent J.L. Sepsis biomarkers: a review. Crit. Care 2010, 14:R15.
8. Clyne B., Olshaker J.S. The C-reactive protein. J. Emerg. Med. 1999, 17:1019-1025.
9. Dellinger R., Levy M., Rhodes A., Annane D., Gerlach H., Opal S., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013, 39:165-228.
10. Dombrovskiy V., Martin A., Sunderram J., Paz H. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit. Care Med. 2007, 35:1414-1415.
11. Harlen J.M. Endothelial Activation and Dysfunction in Sepsis. Endothelial Dysfunction and Inflammation 2010, 1-13. Springer Basel AG, Basel. S.M. Dauphinee, A. Karsan (Eds.).
12. Hoesel L., Ward P. The Role of the Endothelium in Systemic Inflammatory Response Syndrome and Sepsis. Endothelial Biomedicine 2007, 1294-1302. Cambridge University Press, New York. W.C. Aird (Ed.).
13. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit. Care Med. 2006, 34:2596-2602.
14. Jones A., Trzeciak S., Kline J. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit. Care Med. 2009, 37(5):1649-1654.
15. Kinasewitz G., Yan S., Basson B., Comp P., Russell J., Cariou A., et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism. Crit. Care 2004, 8(2):R82-R90.
16. Koh C.Y., Kim Y.S., Shin T.Y., Ha Y.R. Comparing the usefulness of the initial acute physiological and chronic health evaluation (APACHE) II score in the emergency department (ED) and the mortality in emergency department sepsis (MEDS) score for predicting the prognosis of septic patients admitted. Korean J. Crit. Care Med. 2008, 23(2):90-95.
17. Lassalle P., Molet S., Janin A., Van der Heyden J., Tavernier J., Fiers W., et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J. Biol. Chem. 1996, 271:20458-20464.
18. Levi M., Schultz M. Coagulopathy and platelet disorders in critically ill patients. Minerva Anestesiol. 2010, 76(10):851-859.
19. Levi M., van der Poll T. Coagulation in sepsis: all bugs bite equally. Crit. Care 2004, 8:99-100.
20. Levi M., ten Hate C., van der Poll T. Endothelium: interface between coagulation and inflammation. Crit. Care Med. 2002, 30(SV):220-224.
21. Levy M., Fink M., Marshall J., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003, 31(4):1250-1256.
22. Moore L., McKinley B., Turner K., Rob S., Sucher J., Valdivia A., et al. The epidemiology of sepsis in general surgery patients. J. Trauma 2011, 70(3):672-680.
23. Oberhofer D., Kucisec-Tepes N., Skok J., Vucic N., Cala K. Coagulation tests in septic surgical patients. Acta Med. Croatica 2004, 58(5):389-394.
24. Paulus P., Jennewein C., Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?. Biomarkers 2011, 16(SI):11-21.
25. Petaja J. Inflammation and coagulation: an overview. Thromb. Res. 2011, 127(SII):34-37.
26. Rennel E., Mellberg S., Dimberg A., Petersson L., Botling J., Ameur A., et al. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp. Cell Res. 2007, 313:1285-1294.
27. Sarrazin S., Lyon M., Deakin J.A., Guerrini M., Lassalle P., Delehedde M., et al. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. Glycobiology 2010, 20(11):1380-1388.
28. Scherpereel A., Depontieu F., Grigoriu B., Cavestri B., Tsicopoulos A., Gentina T., et al. Endocan, a new endothelial marker in human sepsis. Crit. Care Med. 2006, 34(2):532-537.
29. Schlichting D., Waxman A., O'Brien L., Wang T., Naum C., Rubeiz G., et al. Circulating endothelial and endothelial progenitor cells in patients with severe sepsis. Microvasc. Res. 2011, 81(2):216-221.
30. Schouten M., Wiersinga W., Levi M. Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 2008, 83:536-545.
31. Semeraro N., Ammollo C.T., Semeraro F., Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 2012, 129(3):290-295.
32. Stevenson E.K., Rubenstein A.R., Radin G.T., Wiener R.S., Walkey A.J. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit. Care Med. 2014, 42(3):625-631.
33. Vincent J.L., Moreno R. Clinical review: scoring systems in the critically ill. Crit. Care 2010, 14:207.
34. Xing K., Murthy S., Liles W.C., Singh J.M. Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Crit. Care 2012, 16:R7.
35. Zakariah A., Cozzi S., Van Nuffelen M., Clausi C., Pradier O., Vincent J.L. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit. Care Med. 2008, 36:1507-1512.
36. Zhang W., Lin Z.F., Qu J.L., Chang L. Coagulation disorders are associated with severity of sepsis in infected patients admitted to emergency department. Chin. J. Emerg. Med. 2012, 21(2):123-127.